Program

Co-Chairs

Sero Andonian @my_urologist
Bobby Shayegan

Committee Members

Lorne Aaron
Chasta Bacsu @bacsu_c
Monica Farcas
Soojin Kim
Girish Kulkarni  @GSK_UofT
Andrea Lantz Powers
Anjali Lobo @AnjLoboMD
Katherine Moore
Premal Patel @PremalPatelMD
Stephen Pautler
Mélanie Aubé-Peterkin @MelAubeMD
Ricardo Rendon @RicardoARendon
Keith Rourke @urethrologist
Stephanie Tatzel

Agenda-at-a-Glance

Master of Ceremonies: Robert Hamilton

  • 19:00 - 19:30 ET

Poster Reception

Bladder Cancer

Trimodality Therapy: A Growing Consideration in the Treatment of MIBC

State-of-the-Art Lecture

As a result of attending this session, participants will be able to:

  • Describe the rationale and patient selection for trimodality therapy for muscle invasive bladder cancer (MIBC).
  • Discuss optimal systemic therapies for trimodality therapy
  • Report contemporary cancer and treatment outcomes

  • 20:00 - 20:45 ET
  • Roger Buckley, Masoom Haider, Eric Hyndman
  • Stephen Pautler

EF1: Advances in Prostate Biopsy: Improving Yield and Minimizing Harm

Educational Forum

As a result of attending this session, participants will be able to:

  • Describe the use of MRI and MRI fusion biopsies in the diagnosis of prostate cancer
  • Review microultrasound approaches to prostate biopsy and compare with other modalities
  • Discuss the safety and effectiveness of transperineal prostate biopsy

  • 20:45 - 20:55 ET
  • Ricardo Rendon

ADT Adverse Events and Management Strategies

Guidelines

As a result of attending this session, participants will be able to:

  • Discuss the most common side effects of ADT
  • Gain insight into the recommendation for prevention of complications from use of ADT
  • Review ways to engage PCPs in the management of patients receiving ADT

  • 20:55 - 21:15 ET

Break

Prostate Cancer

The Role of Surgery in High Risk Prostate Cancer

State-of-the-Art Lecture

As a result of attending this session, participants will be able to:

  • Define high-risk prostate cancer
  • Understand the limitations to the available data surrounding surgery and radiation therapy in high risk prostate cancer
  • Identify the need for investigating imaging, genomics and therapies for high risk prostate cancer.

  • 21:45 - 22:15 ET

Noah Stern,

Western University

The impact of ethnicity on prostate cancer mortality in Canada

Jethro Kwong,

University of Toronto

End-to-end deployment of an explainable machine learning model to predict risk of side-specific extraprostatic extension in men with prostate cancer

Thomas Southall,

Memorial University of Newfoundland

Magnetic resonance imaging – ultrasound fusion targeted prostate biopsies: Finding prostate cancer in patients with previously negative biopsies and elevated PSA

Fred Saad,

Centre Hospitalier de l’Université de Montréal

Molecular determinants associated with long-term response to apalutamide (APA) in nonmetastatic castration-resistant prostate cancer (nmCRPC)

Narhari Timilshina,

University of Toronto

Quality of care during active surveillance in low risk prostate cancer patients: A population-based approach

Nawar Touma,

McGill University

Type of androgen deprivation therapy and the risk of cardiovascular diseases in patients with prostate cancer with or without pre-existing cardiovascular risk

  • Moderator: Anil Kapoor

Prostate Cancer

Podium & Rapid Fire Abstracts

As a result of attending this session, participants will be able to:

  • Explore risk modelling for prostate cancer including: active surveillance, EPE and mortality.
  • Discuss medical management including ADT and apalutamide.
  • Explore MRI Fusion biopsy and the role in clinical practice

Master of Ceremonies: Keith Jarvi

  • 19:00 - 19:30 ET

Poster Reception

Male Infertility

Restorative Therapies for Erectile Dysfunction

State-of-the-Art Lecture

As a result of attending this session, participants will be able to:

  • Understand where restorative therapies fit in the erectile dysfunction treatment algorithm
  • Discuss the differences between Gainswave shockwave & Low intensity shockwave therapy as well as PRP & Stromal vascular fraction for ED
  • Evaluate the mechanisms at play for shockwave and PRP 

  • 20:00 - 20:45 ET
  • Trustin Domes, Matt Roberts, Rhonda St. Croix, Susan Moffatt-Bruce
  • Keith Rourke

EF2: Maintaining Professional Competency in the COVID-19 Era

Educational Forum

As a result of attending this session, participants will be able to:

  • Explain the potential impact of COVID-19 on acquisition of knowledge and technical skills
  • Describe changes to medical education at all levels as a result of COVID-19
  • Integrate some strategies for continuous professional development into the “new normal”

  • 20:45 - 20:55 ET
  • Ethan Grober

Testosterone Deficiency

Guideline

As a result of attending this session, participants will be able to:

  • Review the risk factors and health implications of testosterone deficiency.
  • Summarize the diagnostic approach and treatment strategies for testosterone deficiency.
  • Review and update the historical controversies surrounding testosterone therapy.

  • 20:55 - 21:15 ET

Break

Legal

Virtual Consultations during COVID: Medico-Legal Considerations

State-of-the-Art Lecture

As a result of attending this session, participants will be able to:

  • Explain the concept of “reasonable care”
  • Identify three privacy considerations related to providing virtual care
  • Explain two considerations in managing wait times when resuming in-person care

  • 21:45 - 22:15 ET

Curtis Nickel,

Queen's University

Sublingual vaccination with MV140 prevents recurrent urinary tract infections in women: Preliminary results from a randomized, double-blind, placebo-controlled trial

Jeannette Johnstone,

Queen's University

Influence of the COVID-19 pandemic on the burnout rates of graduating Canadian urology residents

Bonnie Liu,

Western University

Prospective evaluation of postoperative pain and opioid use after minor urologic surgery

MayLynn Ding,

McMaster University

Survey of Canadian urology residency programs: Perception of virtual education during the COVID19 pandemic and beyond

David Mikhail,

Lenox Hill Hospital, Manhattan, NY

Development and National implementation of virtual urology electives during COVID-19 pandemic

Travis LeBlanc,

University of Alberta

The impact of COVID-19 on urology resident surgical experience: An analysis of national case logs

  • Moderator: Premal Patel

Infections and Beyond

Podium & Rapid Fire Abstracts

As a result of attending this session, participants will be able to:

  • Understanding the implications of COVID-19 on Canadian urology residency education
  • Understanding the potential role of MV140 vaccination in preventing recurrent urinary tract infections
  • Understanding postoperative opiod use after minor urologic surgery

Master of Ceremonies: Kenneth Pace

  • 19:00 - 19:30 ET

Poster Reception

BPH

Is HoLEP the New Gold Standard for BPH Procedures?

State-of-the-Art Lecture

As a result of attending this session, participants will be able to:

  • Identify the potential complications of HoLEP including retrograde ejaculation, incontinence and retreatment rates
  • Identify the criteria for HoLEP to be performed as an outpatient procedure without an indwelling catheter
  • Identify the benefits of HoLEP compared to TURP with regards to objective voiding parameters and short and long term follow up

  • 20:00 - 20:45 ET
  • Mélanie Aubé-Peterkin, Blair Egerdie, Dean Elterman, Amy Krambeck
  • Naeem Bhojani

EF3: The Evolution of BPH Surgical Management: Outpatient Treatment of Large Volume Prostate Glands

Educational Forum

As a result of attending this session, participants will be able to:

  • Appreciate the advantages of BPH outpatient treatment
  • Compare the different surgical options available for BPH outpatient treatment
  • Understand the limits of various surgical options available for BPH outpatient treatment

  • 20:45 - 20:55 ET
  • Jason Lee

Ureteral Calculi

Guideline

Participants will understand the evidence-based recommendations for:

  • The conservative management of ureteral calculi
  • Indications, optimization and comparative analysis of SWL vs ureteroscopy with laser lithotripsy for ureteral calculi
  • The management of ureteral calculi in special clinical situations (eg pregnancy, paediatrics) 

  • 20:55 - 21:15 ET

Break

Stones

Optimizing Surgical Stone Outcomes: Reducing Residual Fragments

State-of-the-Art Lecture

As a result of attending this session, participants will be able to:

  • Understand the true stone free rate of current surgical stone procedures
  • Be familiar with the outcomes of residual stone fragments
  • Be aware of measures to improve stone free rates

  • 21:45 - 22:15 ET

Jeannette Johnstone,

Queen's University

The association of new onset diabetes and medical therapy for benign prostatic hyperplasia

Dean Elternman,

University Health Network Toronto

Large, multi-center, prospective registry of Rezūm water vapor therapy benign prostatic enlargement

Michael Ordon,

University of Toronto

Incidence and treatment trends for kidney stones in Canada: A population-based cohort study

Ahmed Ibrahim,

McGill University Health Center

GreenLight laser prostatectomy: Are outcomes sustainable after a decade of surgery? A single-center experience with up to 15 years’ follow-up

Runhan Ren,

University of Alberta

Antibiotic use and microbial resistance patterns in patients with ureteric stents

Vardhil Gandhi,

University of Alberta

Analgesic use after endourologic surgery: A provincial analysis of 13,000 patients

  • Moderator: Monica Farcas
Prize Essay Competition Winner: Jeannette Johnstone, Queen's Urology POD-3

Endourology

Podium & Rapid Fire Abstracts

As a result of attending this session, participants will be able to:

  • Understand the potential benefits of Greenlight laser therapy and Rezūm water vapor therapy for BPH
  • Have better knowledge of the incidence and treatment trends of kidney stones in Canada
  • Have a better understanding of analgesic use after endoscopic surgery and antibiotic use in stented patients

Master of Ceremonies: Mike Chetner

  • 19:00 - 19:30 ET

Poster Reception

Upper Tract

Upper tract TCC: Systemic Therapy Strategy

State-of-the-Art Lecture

As a result of attending this session, participants will be able to:

  • Consider the evidence for adjuvant and neoadjuvant treatment in UTUC
  • Discuss the findings from the POUT trial
  • Implement into daily practice

  • 20:00 - 20:45 ET
  • Adrian Fairey, Girish Kulkarni, Ross Mason
  • Peter Black

EF4: Management of High Risk NMIBC

Educational Forum

As a result of attending this session, participants will be able to:

  • Appreciate the advantages of BPH outpatient treatment
  • Stratify risk in patients with non-muscle invasive bladder cancer in order to select patients for immediate cystectomy.
  • Optimize first line therapy for patients with high risk non-muscle invasive bladder cancer.
  • Understand the clinical trials landscape and newly approved agents for BCG-unresponsive high risk non-muscle invasive bladder cancer.

  • 20:45 - 20:55 ET
  • Wes Kassouf

NMIBC

Guideline

As a result of attending this session, participants will be able to:

  • Discuss a risk-stratified approach to treatment of NMIBC
  • Identify patients who might benefit from early cystectomy
  • Define current and future bladder preservation options for BCG-unresponsive NMIBC

  • 20:55 - 21:15 ET

Break

CUASF Lecture

Surgical Blood Loss and Transfusion in Urology: A Gram of Prevention is Worth a Unit of Cure

As a result of attending this session, participants will be able to:

  • Learn about blood loss and transfusion in urology compared to other surgical specialties
  • Review the harms of surgical blood loss and blood transfusion
  • Learn methods of blood loss and transfusion prevention

  • 21:45 - 22:15 ET

Marian Wettstein,

University Health Network Toronto

Patient trajectories of a real-world cohort initiating neoadjuvant chemotherapy for localized muscle-invasive bladder cancer: A population-based study analyzed by a multi-state modelling framework

Kashif Visram,

Queen's University

Sexual dimorphism in outcomes of non-muscle invasive bladder cancer: A role of CD163+ macrophages, B cells and PD-L1 immune checkpoint

Amanda Hird,

University of Toronto

Association between chronic urinary catheterization and bladder cancer incidence and mortality: A population-based study

Steven Lu,

University of Calgary

Assessment of the alignment between research funding allocation and consensus research priority areas in kidney cancer

Alice Dragomir,

McGill University

Role of the upfront cytoreductive nephrectomy in patients with metastatic renal cell carcinoma

Peter Gariscsak,

Queen's University

Minimizing follow-up intensity of active surveillance for clinical stage 1 non-seminoma germ cell tumours (CS1 NSGCT): A 40-year experience at Princess Margaret Cancer Centre

  • Moderator: Luke Lavallée

Non-Prostate GU Cancers

Podium & Rapid Fire Abstracts

As a result of attending this session, participants will be able to:

  • Understand how to best select patients with advanced urologic cancers for therapy
  • Understand how to optimize and limit the burden of follow up for patients after cancer treatment
  • Understand how funding relates to prioritization of research goals in health care

Master of Ceremonies: J.P. Capolicchio

  • 19:00 - 19:30 ET

Poster Reception

Pediatrics

Vesicoureteral Reflux: Better Alone Than in Bad Company

State-of-the-Art Lecture

As a result of attending this session, participants will be able to:

  • Identify factors that increase adverse outcomes among vesicoureteral reflux patients
  • Understand risks associated with continuous antibiotic prophylaxis usage
  • Recognize the impact of adherence in vesicoureteral reflux management

  • 20:00 - 20:45 ET
  • Hillary Copp, Ashley Cox, Dawn MacLellan, Hadley Wood
  • Peter Metcalfe

EF5: Neurogenic bladder through their lifetime

Educational Forum

As a result of attending this session, participants will be able to:

  • Identify common anomalies with long-term implications
  • Incidence and subsequent revisions after pediatric urologic surgery
  • Identify best practice for successful transition to adult urologic follow-up

  • 20:45 - 20:55 ET
  • Anil Kapoor

CUASF Grant Recipients 2021

  • 20:55 - 21:15 ET

Break

Reconstruction

Late Effects Following Pediatric Bladder Operations for Congenital Conditions

State-of-the-Art Lecture

As a result of attending this session, participants will be able to:

  • Cite indications for cross sectional imaging and/or cystoscopy for patients with prior bladder reconstructions
  • Describe a basic evaluation of an incontinent or obstructed continent channel (Mitrofanoff) and indications for different surgical approaches based on that evaluation
  • Explain the urologists role in screening and treatment of pressure ulcers in adults with spina bifida

  • 21:45-22:15 ET

Mélanie Aube-Peterkin,

Urology, McGill University Health Center, Montreal

The Optilume Drug Coated Balloon for recurrent anterior urethral strictures: 3-year results for the ROBUST I study

Jennifer Locke,

Surgery, Sunnybrook Health Sciences Centre, University of Toronto

Impact of delayed recognition of Iatrogenic ureteric injury in a retrospective population-based study

Anna Black,

Urologic Sciences, University of British Columbia

Contemporary risk factors for ureteral stricture following renal transplantation

Yilong Li,

Schulich School of Medicine & Dentistry, Western University, London

Meta-analysis to study the outcomes of early versus expectant management of pediatric neurogenic bladder

Amr Hodhod,

Pediatric Urology, Alberta Children's Hospital, Calgary

Can we improve the usefulness of the diuretic renogram in the diagnosis of UPJO? Introduction of Mercaptoacetyltriglycine-Suspected Obstruction Scoring System (MAG-SOS)

Steven Tong,

Surgery, Division of Urology, University of Alberta, Edmonton

Surgical outcomes in patients undergoing ileovesicostomy in Edmonton over the past 12 years

  • Moderator: Katherine Moore

Pediatric and Adult Reconstruction

Podium & Rapid Fire Abstracts

As a result of attending this session, participants will be able to:

  • Recognize challenges in the diagnosis and the management of urethral pathologies
  • Enumerate challenging issues in pediatric urology practice

  • 22:15-22:30 ET

CUA Awards

LEARNING OBJECTIVES:

As a result of attending this meeting, participants will be able to:

  • Discuss the management of patients with urologic diseases during the COVID pandemic
  • Review the optimal management of patients with urological cancers
  • Assess issues around today’s practice leading to physician burnout and strategies to improve wellness
  • Analyze strategies and practices to increase our quality of care in functional urology
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the Canadian Urological Association. Participants are able to claim 12 hours of credit.

CUA Corporate Contributors

2021 © Canadian Urological Association

corporate.office@cua.org

Facebook-f
Linkedin-in
Twitter
Instagram

To learn more about CUA, please visit: www.cua.org